LONGEVICA PHARMACEUTICALS, INC.

Follow

Organization

MONMOUTH JUNCTION, NJ, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compounds inhibiting eukaryotic elongation factor 2 kinase activity
- Patent number 10,106,552
- Issue date Oct 23, 2018
- Longevica Pharmaceuticals, Inc.
- John H. Dodd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Compounds Inhibiting Eukaryotic Elongation Factor 2 Kinase Activity
- Publication number 20160318948
- Publication date Nov 3, 2016
- Longevica Pharmaceuticals, Inc.
- John H. Dodd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 2

Research Projects

Information Research Project
Use of EF2K inhibitors to inhibit tumor growth and sensitize cancer...
- Application id 8905391
- Award notice date Jun 10, 2015
Information Research Project
Use of EF2K Inhibitors to Reduce Toxicity to Normal Tissues in Chem...
- Application id 8782369
- Award notice date Jul 28, 2014